MD on staff
Oklahoma Pain Treatment Centers - Blake Christensen D.O.
- Arthritis Treatment
- Stem Cell Therapy
Oklahoma City, OK
Stem Cell Therapy clinics in Oklahoma City
Oklahoma City supports a regenerative medicine market shaped by both private clinics and regional academic medicine. Local referral networks run through OU Medical Center, Integris Baptist, and Mercy Health, and stem cell practice in the area spans Nichols Hills, Edmond border, and the Medical District. Patient demand splits across three buckets: orthopedic injections for active adults and aging athletes, neurological and autoimmune protocols marketed to longevity-focused patients, and IV-based allogeneic products offered by private wellness clinics. The FDA classifies most stem cell injections for orthopedic, neurological, or longevity use as investigational biologics under 21 CFR Part 1271, meaning they require either a Biologics License or an active Investigational New Drug authorization. Autologous bone marrow and adipose products may qualify as Section 361 when minimally manipulated and used for homologous function. Oklahoma regulates physician practice through the State Board of Medical Licensure and Supervision. There is no Oklahoma-specific stem cell statute, so federal 21 CFR Part 1271 rules apply. The 3 Oklahoma City clinics listed below have been reviewed against our vetting criteria, including federal NPI lookup, OIG exclusion screening, and Oklahoma Board of Medical Licensure licensure checks.
Rejuvenate Health & Wellness Lounge
- Stem Cell Therapy
- NAD IV Therapy
- Vitamin IV Therapy
- PRP Therapy
- Shockwave Therapy
Ethos Wellness Center
- IV Therapy
- Acne Treatment
- Arthritis Treatment
- Red Light Therapy
- Peptide Therapy
Regulatory context
A note on Oklahoma's stem cell therapy rules.
Oklahoma cellular therapy is governed by 21 CFR Part 1271. Section 361 covers minimally manipulated HCT/Ps used for homologous use without premarket approval. Section 351 covers products that are more than minimally manipulated, used non-homologously, or combined with another article, and these require an IND for clinical use or a BLA for marketing. Most stem cell, stromal vascular fraction, and exosome therapies marketed in Oklahoma for orthopedic, neurologic, and longevity indications are Section 351 biologics that lack FDA approval. Oklahoma's regulatory environment relies on federal law and the Oklahoma Allopathic Medical and Surgical Licensure and Supervision Act.
-
Oklahoma Allopathic Medical and Surgical Licensure and Supervision Act, 59 OS Section 480 et seq
Establishes MD licensure and discipline through the Oklahoma State Board of Medical Licensure and Supervision. -
Oklahoma Osteopathic Medicine Act, 59 OS Section 620 et seq
Establishes DO licensure and discipline through the Oklahoma State Board of Osteopathic Examiners. -
Oklahoma Pharmacy Act, 59 OS Section 353 et seq
Regulates compounding pharmacies aligned with federal 503A and 503B standards.
The FDA has corresponded with Oklahoma providers offering cellular therapies. The Oklahoma State Board of Medical Licensure and Supervision and the Board of Osteopathic Examiners have disciplined physicians for unprofessional conduct including misleading regenerative medicine advertising. The Oklahoma Attorney General can pursue deceptive marketing under the Oklahoma Consumer Protection Act. Oklahoma's smaller market means enforcement is less frequent than in larger states, but federal warning letters apply nationally.